Rubicon Research Ltd (RUBICON) — share price & stock analysis
From losses in FY22 and FY23 to record profits — the comeback is real, the price knows it.
Rubicon Research Ltd (RUBICON) trades at ₹1,368 as of 1 July 2026. The machine reads this as turnaround: from losses in FY22 and FY23 to record profits — the comeback is real, the price knows it. the price is in Stage 2 — advancing, 29 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 100/100 (all improving).
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Market cap
- ₹22,628 Cr
- P/E
- 91.7×
- ROE
- 27.0%
- Book value / share
- ₹78.1
- Revenue (FY26)
- ₹1,754 Cr
- Profit after tax (FY26)
- ₹247 Cr
- Weinstein stage
- Stage 2 (29 weeks)
- Data as of
- 1 July 2026
Profits swing violently in this business — real losses in FY22 and FY23. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit
Where the clock stands now: earnings sit at 100% of their historical range, margins are near the top of their band, and valuation history is thin. That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit
5 of the 5 things we track are currently moving the right way — nearly everything is pulling in the same direction.
Where the levels actually stand: ROCE 28% — a high-quality engine; effectively no debt; margins near the top of their band. Momentum says which way things are moving; these say where they are.
Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double.
The price is in a confirmed uptrend — 29 weeks and counting
STAGE 2 · ADVANCING · 29 WEEKSStock prices move through four repeating stages: basing (1), advancing (2), topping (3) and declining (4). This one is in Stage 2: advancing, 29 weeks in, confirmed.stage
The price sits above its rising 200-day average (₹872 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200
What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200
Data: Weekly price, moving averages and stage
| Period | Price (₹) | 200-DMA (₹) | 50-DMA (₹) | Stage |
|---|---|---|---|---|
| Oct 25 | 619 | 628 | 628 | 4 |
| Oct 25 | 577 | 627 | 623 | 4 |
| Oct 25 | 618 | 626 | 621 | 4 |
| Nov 25 | 627 | 627 | 624 | 4 |
| Nov 25 | 714 | 628 | 628 | 1 |
| Nov 25 | 678 | 632 | 642 | 1 |
| Nov 25 | 656 | 633 | 645 | 1 |
| Dec 25 | 636 | 633 | 643 | 1 |
| Dec 25 | 636 | 633 | 641 | 1 |
| Dec 25 | 656 | 633 | 641 | 1 |
| Dec 25 | 682 | 635 | 647 | 1 |
| Jan 26 | 661 | 637 | 651 | 2 |
| Jan 26 | 651 | 638 | 655 | 2 |
| Jan 26 | 676 | 640 | 658 | 2 |
| Jan 26 | 650 | 641 | 658 | 2 |
| Feb 26 | 679 | 643 | 661 | 2 |
| Feb 26 | 785 | 648 | 678 | 2 |
| Feb 26 | 785 | 655 | 697 | 2 |
| Feb 26 | 780 | 661 | 714 | 2 |
| Feb 26 | 780 | 667 | 726 | 2 |
| Mar 26 | 766 | 671 | 732 | 2 |
| Mar 26 | 769 | 676 | 741 | 2 |
| Mar 26 | 783 | 680 | 745 | 2 |
| Mar 26 | 768 | 684 | 749 | 2 |
| Apr 26 | 775 | 687 | 752 | 2 |
| Apr 26 | 836 | 693 | 763 | 2 |
| Apr 26 | 899 | 699 | 776 | 2 |
| Apr 26 | 939 | 710 | 804 | 2 |
| Apr 26 | 970 | 720 | 828 | 2 |
| May 26 | 956 | 733 | 854 | 2 |
| May 26 | 961 | 743 | 871 | 2 |
| May 26 | 950 | 754 | 890 | 2 |
| May 26 | 1,006 | 763 | 903 | 2 |
| Jun 26 | 1,298 | 783 | 956 | 2 |
| Jun 26 | 1,203 | 787 | 966 | 2 |
| Jun 26 | 1,171 | 795 | 982 | 2 |
| Jun 26 | 1,188 | 798 | 990 | 2 |
| Jun 26 | 1,296 | 808 | 1,013 | 2 |
| Jun 26 | 1,368 | 824 | 1,052 | 2 |
| Jun 26 | 1,362 | 834 | 1,073 | 2 |
| Jun 26 | 1,392 | 851 | 1,109 | 2 |
| Jun 26 | 1,417 | 856 | 1,121 | 2 |
| Jul 26 | 1,368 | 872 | 1,152 | 2 |
From losing money in FY22 and FY23 to record profits
Over 6 years, sales went from ₹263 Cr to ₹1,754 Cr (about 37% a year), and profit from ₹49.0 Cr to ₹247 Cr.revenuenet_profit
The books show real losses in FY22 and FY23 (worst: ₹−67.0 Cr). Everything about today’s cheap-looking numbers must be read against that history — the recovery is what you are buying.net_profit
Data: Revenue by year
| Period | Revenue (₹ Cr) |
|---|---|
| FY20 | 263 |
| FY21 | 315 |
| FY22 | 314 |
| FY23 | 394 |
| FY24 | 854 |
| FY25 | 1,284 |
| FY26 | 1,754 |
Data: Profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| FY20 | 49 |
| FY21 | 31 |
| FY22 | -67 |
| FY23 | -17 |
| FY24 | 91 |
| FY25 | 134 |
| FY26 | 247 |
Data: OPM % by year
| Period | OPM % (%) |
|---|---|
| FY20 | 30.8 |
| FY21 | 29.2 |
| FY22 | -12.4 |
| FY23 | 4.6 |
| FY24 | 18.1 |
| FY25 | 19.9 |
| FY26 | 22.8 |
Sales exploded 44% last quarter
Mar 26 sales were ₹514 Cr, up 44% on the same quarter last year.revenue
Data: Quarterly sales
| Period | Revenue (₹ Cr) | YoY growth (%) |
|---|---|---|
| Sep 24 | 296 | – |
| Dec 24 | 313 | – |
| Mar 25 | 358 | – |
| Jun 25 | 352 | – |
| Sep 25 | 412 | 39.2 |
| Dec 25 | 476 | 52.1 |
| Mar 26 | 514 | 43.6 |
Margins are widening — 20% → 23% in a year
Of every ₹100 of sales, the company keeps ₹23.1 as operating profit (a year ago it kept ₹20.2).opm_pct
Zoom out and this is the page's quiet hero: annual operating margin bottomed at −12.4% in FY22 and has been rebuilt to 22.8% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit
The gross margin barely moved (69% → 67%), so the change came from running costs — the business is getting more efficient as it scales.gpm_pctopm_pct
Data: Three margins, quarterly
| Period | Gross (%) | Operating (%) | Net (%) |
|---|---|---|---|
| Sep 24 | 73.3 | 20.8 | 11.7 |
| Dec 24 | 68.5 | 22.3 | 12.2 |
| Mar 25 | 68.8 | 20.2 | 10.1 |
| Jun 25 | 70.8 | 22.5 | 12.3 |
| Sep 25 | 69.3 | 22.9 | 13.1 |
| Dec 25 | 66.9 | 22.7 | 15.3 |
| Mar 26 | 67.1 | 23.1 | 14.9 |
Profit exploded 114% — mostly from selling more
Mar 26 profit after tax was ₹77.0 Cr, up 114% year on year.net_profit
Data: Quarterly profit after tax
| Period | PAT (₹ Cr) | YoY growth (%) |
|---|---|---|
| Sep 24 | 34.0 | – |
| Dec 24 | 38.0 | – |
| Mar 25 | 36.0 | – |
| Jun 25 | 43.0 | – |
| Sep 25 | 54.0 | 58.8 |
| Dec 25 | 73.0 | 92.1 |
| Mar 26 | 77.0 | 113.9 |
The single biggest driver was selling more.
Data: Where the profit change came from (Mar 25 → Mar 26)
| Component | Effect (₹ Cr) |
|---|---|
| PAT Mar 25 | 36 |
| More sales | +31 |
| Fatter margins | +16 |
| Other income | +3 |
| Depreciation | −2 |
| Interest | +2 |
| Tax | −7 |
| Everything else | −2 |
| PAT Mar 26 | 77 |
Most of the profit becomes cash — but not all
Over the last 3 profitable years, the business reported ₹472 Cr of profit and collected ₹385 Cr of operating cash — about 82% conversion (2 loss years excluded — a negative denominator would flatter the ratio).operating_cash_flownet_profit
The gap sits in receivables: customers now take 106 days to pay, up from 92. Profit booked, cash pending.debtor_days
Data: Cash collected vs profit reported (annual)
| Period | Operating cash flow (₹ Cr) | Profit after tax (₹ Cr) |
|---|---|---|
| FY20 | 5.0 | 49.0 |
| FY21 | 62.0 | 31.0 |
| FY22 | -63.0 | -67.0 |
| FY23 | -75.0 | -17.0 |
| FY24 | 21.0 | 91.0 |
| FY25 | 159 | 134 |
| FY26 | 205 | 247 |
The cash cycle is tightening — money comes home faster
One rupee now takes about 337 days to go out the door as materials and come back as collected cash — down from 403 days the year before.cash_conversion_cycle
The biggest mover: inventory moving faster off the shelf (574 → 479 days).inventory_days
Data: Days of cash locked up (annual)
| Period | Customers owe (debtor days) (days) | Stock on shelf (inventory days) (days) | We owe suppliers (payable days) (days) |
|---|---|---|---|
| FY20 | 194 | 360 | 183 |
| FY21 | 158 | 508 | 271 |
| FY22 | 162 | 502 | 320 |
| FY23 | 209 | 609 | 353 |
| FY24 | 129 | 428 | 252 |
| FY25 | 92.0 | 574 | 263 |
| FY26 | 106 | 479 | 248 |
The asset base keeps compounding — this company builds
The productive asset base has gone from ₹157 Cr (FY20) to ₹532 Cr, with another ₹40.0 Cr of capacity under construction right now.fixed_assetscwip
The build is bigger than the cash engine: investing outflows (₹543 Cr) exceeded operating cash (₹385 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow
Data: Assets in place vs under construction (annual)
| Period | Fixed assets (₹ Cr) | Under construction (CWIP) (₹ Cr) |
|---|---|---|
| FY20 | 157 | 2.0 |
| FY21 | 188 | 6.0 |
| FY22 | 193 | 3.0 |
| FY23 | 199 | 25.0 |
| FY24 | 307 | 10.0 |
| FY25 | 327 | 7.0 |
| FY26 | 532 | 40.0 |
Debt is small — but no longer zero, and growing
For every ₹100 shareholders have put in (and left in), the company has borrowed ₹24 — total borrowings have grown from ₹30.0 Cr to ₹311 Cr over the window.borrowings
The equity base grew even faster, so the ratio stays comfortable — but a 10× rise in absolute borrowings deserves a name (acquisitions, capex), not a shrug. Watch whether it keeps compounding.borrowings
Data: Total borrowings (annual)
| Period | Borrowings (₹ Cr) |
|---|---|
| FY20 | 30.0 |
| FY21 | 93.0 |
| FY22 | 175 |
| FY23 | 320 |
| FY24 | 425 |
| FY25 | 418 |
| FY26 | 311 |
Data: Debt vs shareholders’ money (annual)
| Period | Debt ÷ equity (x) |
|---|---|
| FY20 | 0.1 |
| FY21 | 0.3 |
| FY22 | 0.6 |
| FY23 | 1.1 |
| FY24 | 1.1 |
| FY25 | 0.8 |
| FY26 | 0.2 |
Every ₹100 kept in the business now earns ₹28 — and the number is rising
Return on capital employed is 28.0% (a year ago: 26.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct
Data: Returns on capital (annual)
| Period | ROCE (%) |
|---|---|
| FY21 | 17.0 |
| FY22 | -12.0 |
| FY23 | 1.0 |
| FY24 | 19.0 |
| FY25 | 26.0 |
| FY26 | 28.0 |
Worth studying deeper — with eyes open
The numbers lean positive, and the price is roughly fair to the delivery so far.
Best thing in the data: profit rising (₹36.0 Cr → ₹77.0 Cr).net_profit
Biggest worry: free cash flow falling (₹94.0 Cr → ₹−205 Cr).operating_cash_flow
One dissent worth hearing: our catalysts lens reads negative — “4 earnings trigger(s): Pithampur Capacity Unlock — Gross Margin Recovery, R&D Pipeline Commercialization — 24 Products Under FDA Review, Specialty Portfolio Mix”. When a lens disagrees with the committee, it is usually pointing at the thing that breaks first.
Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.
Straight answers from the data
What does Rubicon Research Ltd do?
Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company engaged in the development, manufacturing, & commercialization of differentiated formulations.[1]. It is listed in the Pharma - Formulators sector with a market capitalisation of ₹22,628 Cr.
What is Rubicon Research Ltd's share price?
As of 1 July 2026, Rubicon Research Ltd trades at ₹1,368, with a market capitalisation of ₹22,628 Cr. Prices are weekly closes from Screener data; this page refreshes with each weekly update.
What is Rubicon Research Ltd's share price target?
Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Rubicon Research Ltd's intrinsic value at ₹994 per share under base assumptions (bear ₹280, bull ₹994), against the current price of ₹1,368 — a 16% premium to model value. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.
What did Rubicon Research Ltd report in its latest quarterly results?
In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹514 Cr, up 44% on the same quarter last year. Mar 26 profit after tax was ₹77.0 Cr, up 114% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.
Is Rubicon Research Ltd growing?
Sales exploded 44% last quarter. Mar 26 sales were ₹514 Cr, up 44% on the same quarter last year.
Are Rubicon Research Ltd's profits growing?
Profit exploded 114% — mostly from selling more. Mar 26 profit after tax was ₹77.0 Cr, up 114% year on year.
What are Rubicon Research Ltd's operating margins?
Margins are widening — 20% → 23% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹23.1 as operating profit (a year ago it kept ₹20.2).
What is Rubicon Research Ltd's long-term growth record?
Revenue grew from ₹263 Cr in FY20 to ₹1,754 Cr in FY26 — a 37.2% compound annual growth rate over 6 years. Profit after tax compounded at 30.9% over the same period (₹49 Cr → ₹247 Cr).
Is Rubicon Research Ltd stock in an uptrend?
The price is in a confirmed uptrend — 29 weeks and counting. Rubicon Research Ltd is in Stage 2 — advancing, 29 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).
Where is Rubicon Research Ltd in its business cycle?
The data reads Rubicon Research Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company. Profits swing violently in this business — real losses in FY22 and FY23. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.
Does Rubicon Research Ltd have too much debt?
Debt is small — but no longer zero, and growing. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹24 — total borrowings have grown from ₹30.0 Cr to ₹311 Cr over the window.
What is the bull case for Rubicon Research Ltd?
From losses in FY22 and FY23 to record profits — the comeback is real, the price knows it. Best thing in the data: profit rising (₹36.0 Cr → ₹77.0 Cr). Sales exploded 44% last quarter.
What is the bear case for Rubicon Research Ltd — what could break the story?
Biggest worry: free cash flow falling (₹94.0 Cr → ₹−205 Cr). Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 22%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.
Is Rubicon Research Ltd a stock worth studying right now?
Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: worth studying deeper — with eyes open. The numbers lean positive, and the price is roughly fair to the delivery so far. Across the 7-model scorecard the composite research signal is study deeper at 76% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.